GNS Healthcare Announces M Financing, MMRF Study Results

By Bio-IT World Staff December 8, 2015 | GNS Healthcare announced a $10M Series C financing round today. New investors in this round—Celgene Corporation, Alexandria Real Estate Equities, and Gi Global Health Fund LP—join previous investors including Cambia Health Solutions, California’s Heritage Provider Network, and Japan’s Mitsui & Co. U.S. subsidiary (“Mitsui USA”). GNS builds cloud-based big data solutions for precision medicine and population health. Earlier this week, the Multiple Myeloma Research Foundation (MMRF) announced preliminary results of a multi-year collaboration with GNS to speed the discovery of innovative treatments for patients with multiple myeloma. GNS used its patented causal machine learning and simulation platform, REFS (Reverse Engineering and Forward Simulation), to analyze data from the CoMMpass Interim Analysis 7 (IA7) dataset, which is composed of extensive clinical and genomic…

Link to Full Article: GNS Healthcare Announces M Financing, MMRF Study Results

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!